Michael Abecassis

Michael Abecassis

Director/Board Member at PHARMACYTE BIOTECH, INC.

Net worth: 13 494 $ as of 2026-07-30

67 year
Consumer Services
Health Technology
Government

Profile

Michael M.
Abecassis
is the founder of Eurofins Transplant Genomics LLC.
Current positions include Independent Director at PharmaCyte Biotech, Inc. since 2017, and Member at the National Institutes of Health, National Institute of Allergy & Infectious Diseases, American Surgical Association, and Society of University Surgeons.
Former roles include Founding Director of the Comprehensive Transplant Center at Northwestern University, Assistant Professor at the University of Iowa, President of the American Society of Transplant Surgeons from 2010 to 2011, and Dean of Clinical Affairs at Feinberg School of Medicine from 2008 to 2011.
Education includes a doctorate from the University of Toronto in 1983 and an MBA from Kellogg School of Management in 2000.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-07-23 23,427 ( 0.22% ) 13 494 $ 2026-07-30

Michael Abecassis active positions

CompaniesPositionStart
PHARMACYTE BIOTECH, INC. Director/Board Member 2017-07-09
Founder -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Michael Abecassis

CompaniesPositionEnd
President 2010-12-31
Corporate Officer/Principal 2010-12-31
Corporate Officer/Principal -
░░░░░░░░░░ ░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Michael Abecassis's experience

Training of Michael Abecassis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

88

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Consumer Services

Consumer Services

Consumer Services

Government

Government

Commercial Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Michael Abecassis